�鶹��ý

Skip to content

Health

Do new Alzheimer's drugs signal the end of the condition?

Antibody treatments that target amyloid plaques in the brains of people with Alzheimer's have shown promise in trials, but questions about their side effects and practicality remain

Insight

Health

New drug donanemab slows cognitive decline in early Alzheimer's

News

Image of a nematode worm

Life

Nematode worms get the ‘munchies’ after having cannabis-like substance

News

Health

Why expanding access to Narcan in the US won’t solve the opioid crisis

Analysis

Health

Legal marijuana in the US may be less potent than packaging claims

News

Health

Drug overdose deaths have quadrupled among older US adults

News

Health

Caffeine linked to lower BMI and reduced risk of type 2 diabetes

News

SARS-CoV-2 could evolve into new variants that may evade existing vaccines

Health

Inhaled powder that coats airways can block coronavirus infection

News

MRI scan of a brain

Health

Sneaking drugs into the brain could treat conditions like Alzheimer's

News

The omicron coronavirus variant binding to a cell's ACE2 receptor

Health

Drug that targets ACE2 receptors may work against new covid variants

A drug that is approved for treating gallstones and liver conditions inhibits cells' ACE2 receptors, which the coronavirus' spike protein binds to

News

Health

Alzheimer's drug lecanemab slows cognitive decline but concerns linger

News

Chemistry

Genetically modified tobacco plant produces cocaine in its leaves

News

Environment

Feeding cows hemp makes them ‘high’ and their milk could be unsafe

News

Health

A daily dose of aspirin raises the risk of falls among older people

News